ProfileGDS5822 / ILMN_2709881
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 20% 53% 1% 28% 8% 19% 53% 54% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 112.820
GSM1276600PDAC Late Ablation Control 225.653
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 13.81
GSM1276603PDAC Late Ablation 214.628
GSM1276604PDAC Late Ablation 37.58
GSM1303940PDAC Late Ablation_anti-CTLA4 112.419
GSM1303941PDAC Late Ablation_anti-CTLA4 227.553
GSM1303942PDAC Late Ablation_anti-CTLA4 33054